2026 Farm Bill Removes 0.3% Delta-9 THC Threshold, Inserts Total THC Standard
The 2026 Farm Bill total THC standard replaces the previous delta-9 THC threshold, closing loopholes in hemp regulation. This change affects THCA-rich hemp products, now treated as marijuana. Farmers can self-designate as industrial hemp, impacting legal…
How the Federal Hemp Ban Could Affect ‘THC-Free’ CBD Products
The federal hemp ban impact is raising concerns for 'THC-free' CBD products that may contain trace THC. New rules could pull trusted wellness products from shelves if minimal THC or synthetic cannabinoids are detected. States with strong hemp industries…
Cannabis Rescheduling Update: Advocates Eye AG Bondi Hearing for Status Report
Cannabis rescheduling update highlights potential easing of research restrictions and tax burdens. Advocates closely watch Attorney General Pam Bondi's hearing for status. This update clarifies that only Congress can legalize recreational marijuana.
Legal Analysis: Hemp Retailers Face ‘Existential Threat,’ Possible Closure or Forced Pivots
Hemp retail store closures are imminent due to new legal bans affecting intoxicating hemp products. This legal analysis highlights the severe disruption and forced pivots facing standalone CBD and hemp retailers. Mail-order hemp sales will also be…
HEMP Act Industry Reactions: ‘No One Will Grow a Crop That Might Be Illegal in November’
Hemp act industry reactions highlight the uncertainty hemp farmers face about crop legality in 2026. Stakeholders stress the need for clear regulations to protect consumer safety. The industry warns of disruption without federal clarity before the…
Congressional Research Service: Enforcement of Hemp Ban ‘Remains Unclear’
Hemp ban enforcement uncertainty is creating significant challenges for the hemp industry in 2026. Federal agencies may lack resources to enforce the ban broadly, causing legal ambiguity. This uncertainty risks driving compliant hemp brands out of…
Patients Who Rely on Hemp-Derived CBD Face Abrupt Disruptions in Care
Hemp CBD patient access is at risk due to upcoming regulatory changes. Patients relying on hemp-derived CBD for affordable care face abrupt disruptions. The new rules lack clinical pathways and patient safeguards.
Global Cannabis Sector 2026: Terpenes, THC Beverages, and Regulatory Momentum
The global cannabis cultivation market forecast for 2026 is projected to reach $244 billion, driven by innovations in terpenes and hemp-derived THC beverages. Regulatory momentum worldwide contrasts with the U.S. moving toward a ban. This evolving…
How the Intermediate Product Rule Hemp Affects CBD Production
The intermediate product rule hemp is a critical regulatory challenge for CBD manufacturing. Even if final CBD products comply, intermediate materials often exceed THC limits. This rule threatens the viability of American hemp production.
Oregon Proposes 17% Tax on Hemp-Derived Cannabinoid Products in 2026 Session
Oregon hemp cannabinoid tax is proposed at 17% in the 2026 legislative session. This tax would apply to industrial hemp-derived cannabinoid products, matching marijuana tax rates. The bill also includes packaging and background check requirements for…